dmd

Hope for Duchenne sufferers around the world

April 27th, 2017

16-year-old Billy Ellsworth is still walking thanks to Western Australian researchers who developed the first drug to address the underlying genetic defect of Duchenne, and the first of its type to be approved by the US Food and Drug Administration.

+ Find out more

Genetic researcher shares insights on TEDxPerth

February 10th, 2017

Professor Steve Wilton

Murdoch University’s Professor Steve Wilton shared insights into his groundbreaking work on developing a revolutionary new treatment for genetic disease with a worldwide audience at TEDx Perth.

+ Find out more

World breakthrough for WA researchers

September 20th, 2016

The FDA has approved a drug developed in Perth by Professors Sue Fletcher and Steve Wilton

The international Duchenne muscular dystrophy community have applauded the announcement by the US Food and Drug Administration (FDA) to approve a drug developed in Perth by Professors Steve Wilton and Sue Fletcher

+ Find out more

WA Innovator of the Year research scientists join rare diseases team

April 10th, 2013

Prominent molecular geneticists Professors Steve Wilton and Sue Fletcher have joined Murdoch’s Centre for Comparative Genomics (CCG).

+ Find out more